178 YanochkoG
Most of the research began in rodents, and much of the practical experience comes from human clinical use
METAOD004: A Phase IIa (double-blind, placebo-controlled, dose escalation) safety study with multiple daily doses (9, 27 or 54 mg AOD9604) administered orally (capsules) for seven days in 36 healthy clinically obese males presenting with a BMI 30 kg/m 2
GHK-Cu is endogenous to the human body (found naturally in plasma, saliva, and urine), and its concentration naturally declines with age
Sermorelin has the longest history of clinical use among this group
The AOD-9604 10mg research peptide is supplied by Ascend Peptides UK for in-vitro research use only, not for human consumption, veterinary, or clinical application